Ortivus — Board/Management Information 2023

Oct 11, 2023

Ortivus' President and CEO, Reidar Gårdebäck has decided to leave the company after nearly 5 years of service

Reidar Gårdebäck will remain with the company until his replacement has been recruited, which is anticipated to be in the spring of 2024.

The Board has accepted Reidar's resignation and will now begin the search process of recruiting a new CEO. We want to thank Reidar for his great contribution to Ortivus over the years; his leadership has been crucial in transforming Ortivus into the company it is today.

For further information, please contact:

Anders Paulsson, Chairman of the Board E-mail: paulsson.anders@me.com

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in realtime, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-10-11 16:10 CEST.

Attachments

Ortivus' President and CEO, Reidar Gårdebäck has decided to leave the company after nearly 5 years of service